{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "CYRAN"}], "original": "By ROBERT CYRAN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"content_kicker": "Breakingviews", "main": "Investors Question Financial Sense of Abbott-St. Jude Deal"}, "print_page": null, "keywords": [{"value": "Abbott Laboratories", "is_major": "N", "rank": "1", "name": "organizations"}, {"value": "St Jude Medical Inc", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "3", "name": "subject"}, {"value": "Medical Devices", "is_major": "N", "rank": "4", "name": "subject"}], "snippet": "Abbott\u2019s $25 billion deal involves hefty borrowing and the company has another acquisition near. Will antitrust authorities allow the combination?", "source": "The New York Times", "lead_paragraph": "Abbott\u2019s $25 billion deal involves hefty borrowing and the company has another acquisition near. Will antitrust authorities allow the combination?", "word_count": "301", "pub_date": "2016-04-29T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/04/29/business/dealbook/investors-question-financial-sense-of-abbott-st-jude-deal.html", "_id": "57223d6738f0d83c404739ba"}